Email alerts
Advanced Search
  • May 25, 2010
    Multiple European Clinical Registries Show Important Benefits of Medtronic CoreValve(R) Transcatheter Aortic Valve System
    Data Demonstrates That Revolutionary Treatment for Patients with Diseased Heart Valves Is Transitioning Successfully into Standard Clinical Practice throughout Europe

    PARIS, May 25, 2010 (BUSINESS WIRE) --New European data from five national clinical registries presented today at EuroPCR report positive clinical outcomes for one of the most exciting emerging...

  • May 25, 2010
    Medtronic's Resolute(R) Drug-Eluting Stent Matches Market-Leading Rival in Large Head-to-Head Study
    One-Year Clinical Results from Innovative RESOLUTE All Comers Trial Show Excellent Performance for Resolute DES in Challenging Patient Population

    PARIS, May 25, 2010 (BUSINESS WIRE) --The highly anticipated first results of the RESOLUTE All Comers study were presented today during the late-breaking clinical trial session of the 2010 EuroPCR...

  • May 20, 2010
    Medtronic Announces 2010 Analyst Meeting and Webcast
    Medtronic Institutional Investor and Analyst Meeting Scheduled for Monday, June 7, 2010, 10 a.m. - 2:30 p.m. Eastern

    MINNEAPOLIS, May 20, 2010 (BUSINESS WIRE) --Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Monday, June 7, 2010, in New York City from 10 a.m. - 2:30 p.m. Eastern...

  • May 20, 2010
    Cardiovascular Devices from Medtronic Featured Prominently at EuroPCR
    Cardiology Meeting in Paris May 25-28 Includes New Data on Resolute(R) Drug-Eluting Stent, IN.PACT Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve

    MINNEAPOLIS, May 20, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), announced today the schedule of important clinical data presentations during EuroPCR, a major cardiology meeting taking...

  • May 19, 2010
    First Patient Treated with Valiant(R) Thoracic Stent Graft in Medtronic's ''RESCUE'' Clinical Study
    Minimally-Invasive Procedure May Stabilize Aortic Bleeding When Surgery Is Not an Option

    MINNEAPOLIS, May 19, 2010 (BUSINESS WIRE) --Further demonstrating its commitment to proving the benefits of minimally-invasive procedures, Medtronic, Inc. (NYSE: MDT), today announced that the...

  • May 17, 2010
    Medtronic CFO Gary Ellis to Speak at the Citi Global Health Care Conference

    MINNEAPOLIS, May 17, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), today announced it will participate in the 2010 Citi Investment Research Global Health Care Conference on Wednesday, May...

  • May 15, 2010
    New Medtronic Data Shows Health Care Utilization Differs by Type of Implantable Defibrillator Therapy
    Studies Presented at Heart Rhythm 2010 Demonstrate Advantages of Advanced Shock Reduction Technologies

    MINNEAPOLIS & DENVER, May 15, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new data from the MVP (Managed Ventricular Pacing) trial that implantable defibrillator patients...

  • May 14, 2010
    Medtronic Announces Date for 2010 Annual Meeting
    Shareholders Invited to Attend Annual Meeting on Aug. 25, 2010

    MINNEAPOLIS & DENVER, May 14, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial data showing the...

  • May 14, 2010
    Medtronic Announces New Data from STOP AF Pivotal Trial
    Trial Demonstrates Significant Decrease in Symptoms and Improved Quality of Life for AF Patients Treated with Arctic Front(R) Cardiac CryoAblation Catheter

    MINNEAPOLIS & DENVER, May 14, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial data showing the...

  • May 13, 2010
    Late Breaking Clinical Trial Validates Value of Shock Reduction Strategies
    New Medtronic Evidence on Shock Reduction Device Programming Strategies Released At Heart Rhythm 2010

    MINNEAPOLIS & DENVER, May 13, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new evidence demonstrating that key shock-reduction programming strategies significantly reduced...

Show 5102550100 per page